Upstream Bio Files Definitive Proxy Statement
Ticker: UPB · Form: DEF 14A · Filed: Apr 17, 2025 · CIK: 2022626
| Field | Detail |
|---|---|
| Company | Upstream Bio, Inc. (UPB) |
| Form Type | DEF 14A |
| Filed Date | Apr 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, sec-filing
TL;DR
Upstream Bio's proxy statement is out for the June 10th meeting. Standard stuff.
AI Summary
Upstream Bio, Inc. filed its definitive proxy statement on April 17, 2025, for its annual meeting on June 10, 2025. The company, located at 890 Winter Street, Suite 200, Waltham, MA, is in the pharmaceutical preparations industry. This filing is a standard procedural document for public companies.
Why It Matters
This filing provides shareholders with information regarding the upcoming annual meeting, including details on director nominations and other corporate governance matters, allowing them to make informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing, which is a standard disclosure document for public companies and does not contain new material information that would typically impact risk.
Key Numbers
- 20250610 — Annual Meeting Date (Shareholders will vote on company matters on this date.)
- 20250417 — Filing Date (The date the proxy statement was officially submitted to the SEC.)
Key Players & Entities
- Upstream Bio, Inc. (company) — Registrant
- 0000950170-25-055372 (filing_id) — Accession Number
- 20250417 (date) — Filing Date
- 20250610 (date) — Meeting Date
- 890 WINTER STREET, SUITE 200 (address) — Business Address
- WALTHAM, MA (address) — Business Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a definitive proxy statement, is a document filed with the SEC by a company that is soliciting its shareholders' votes on important matters, such as the election of directors, at an upcoming shareholder meeting.
When is the shareholder meeting for Upstream Bio, Inc. scheduled?
The shareholder meeting for Upstream Bio, Inc. is scheduled for June 10, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 17, 2025.
Where is Upstream Bio, Inc. located?
Upstream Bio, Inc. is located at 890 Winter Street, Suite 200, Waltham, MA.
What is the Standard Industrial Classification (SIC) code for Upstream Bio, Inc.?
The SIC code for Upstream Bio, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 17, 2025 regarding Upstream Bio, Inc. (UPB).